These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8823305

  • 1. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH.
    J Clin Invest; 1996 Sep 15; 98(6):1400-8. PubMed ID: 8823305
    [Abstract] [Full Text] [Related]

  • 2. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
    Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock JB, Oldfield EH.
    J Neurosurg; 1987 Dec 15; 67(6):880-4. PubMed ID: 3681425
    [Abstract] [Full Text] [Related]

  • 3. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM, Dvorak HF, Brock TA, Senger DR.
    Arch Biochem Biophys; 1993 Feb 15; 301(1):15-20. PubMed ID: 8442657
    [Abstract] [Full Text] [Related]

  • 5. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 15; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.
    Exp Clin Endocrinol Diabetes; 2002 Nov 01; 110(8):386-92. PubMed ID: 12518248
    [Abstract] [Full Text] [Related]

  • 8. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF.
    Oncogene; 1997 May 01; 14(17):2025-32. PubMed ID: 9160882
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
    Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM.
    Am J Pathol; 1997 May 01; 150(5):1673-85. PubMed ID: 9137092
    [Abstract] [Full Text] [Related]

  • 10. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
    Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH.
    J Neurosurg; 1989 Dec 01; 71(6):884-91. PubMed ID: 2585081
    [Abstract] [Full Text] [Related]

  • 11. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S, Iruela-Arispe ML, Harvey VS, Zeng H, Nagy JA, Dvorak HF, Mukhopadhyay D.
    Microvasc Res; 2000 Sep 01; 60(2):112-20. PubMed ID: 10964585
    [Abstract] [Full Text] [Related]

  • 12. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 01; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

  • 13. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S, Datta K, Mukhopadhyay D.
    Cancer Res; 2001 Sep 15; 61(18):6952-7. PubMed ID: 11559575
    [Abstract] [Full Text] [Related]

  • 14. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG, Hasan T.
    Cancer Res; 1993 Jan 01; 53(1):153-7. PubMed ID: 8416739
    [Abstract] [Full Text] [Related]

  • 15. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
    Watanabe Y, Dvorak HF.
    Exp Cell Res; 1997 Jun 15; 233(2):340-9. PubMed ID: 9194496
    [Abstract] [Full Text] [Related]

  • 16. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
    Oku T, Tjuvajev JG, Miyagawa T, Sasajima T, Joshi A, Joshi R, Finn R, Claffey KP, Blasberg RG.
    Cancer Res; 1998 Sep 15; 58(18):4185-92. PubMed ID: 9751633
    [Abstract] [Full Text] [Related]

  • 17. Further characterization of malignant glioma-derived vascular permeability factor.
    Criscuolo GR, Merrill MJ, Oldfield EH.
    J Neurosurg; 1988 Aug 15; 69(2):254-62. PubMed ID: 3134521
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 19. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD, Shi YX, Im SA, Chen X, Yung WK.
    Clin Cancer Res; 2000 Jun 01; 6(6):2562-72. PubMed ID: 10873113
    [Abstract] [Full Text] [Related]

  • 20. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
    Senger DR, Perruzzi CA, Feder J, Dvorak HF.
    Cancer Res; 1986 Nov 01; 46(11):5629-32. PubMed ID: 3756910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.